Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etrasimod Pharmacokinetics in Healthy Lactating Women
NCT07153159Phase 1Completed
- Sponsor
- Pfizer
- Start
- Aug 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of etrasimod in ulcerative colitis (UC), sponsored by Pfizer. Primary endpoints: Area under the etrasimod concentration-time curve in breast milk at Day 8, Maximum observed concentration of etrasimod in breast milk at Day 8 and 4 more. Started Aug 2025; status: completed.
02
Drugs
etrasimod
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07153159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07153159.